1/8/2009
Thursday morning

This topic is closed off and you will be taken directly to the website.

Topics taken from open source list. I hope you find this useful.
This site is for our clients only as an information resource.

In stating that a threshold of effect has never been found for asbestos, Rall stands behind the outdated one fiber can kill theory of carcinogenesis. However, Rall fails to mention data supporting a threshold for chrysotile in lung cancer (11, asbestosis (12), and mesothelioma (13) as well as a panel report from the Health Effects Institute-Asbestos Research (HEI-AR) detailing animal and in vitro dose-response studies exhibiting no-observed adverse effect levels (NOAELs) for asbestos (14). Our recent work documents a dose-dependent increase in asbestos-induced proto-oncogene activation in mesothelial cells with no induction at lowest concentrations of fibers tested and an enhanced potency of crocidolite asbestos in comparison to chrysotile (15).
The Monfalcone area, in northeastern Italy, is a small industrial territory (population about 60,000), with a large shipyard. Between October 1979 and April 1992, ninety-two malignant mesotheliomas were diagnosed at the Monfalcone Hospital. The series included 84 men and 8 women, aged 42 to 89 years (median age 68 years). There were 89 pleural and 3 peritoneal tumors. Seventy patients (69 men and 1 woman) had worked in the shipyards; six were seamen, and four insulators. Five men had been exposed to asbestos in various industries; six women had histories of domestic exposure, and one woman had a history of possible environmental exposure. The latency periods (intervals between first exposure to asbestos and diagnosis of the tumor) ranged from 20 to 65 years (median 52 years). Latency periods among insulators were significantly lower than among shipyard workers, as well as lower than among the other categories (.
In order to provide estimates of the accuracy of death certification of malignant pleural mesothelioma in Italy, the causes of death of a series of ascertained cases were investigated. The study included 523 cases of pleural mesothelioma diagnosed in 1984-1988 by 88 hospital departments and clinics. Vital status at 7 May 1990 was ascertained for 92.7% of subjects. The overall concordance between pathological diagnosis and death certification was about 75%. ___________________________________________________________ Med Lav 1994 Mar-Apr;85(2):157-60
Latency periods (time intervals elapsing between first exposure to asbestos and death) were examined in 421 cases of malignant pleural mesothelioma, diagnosed in the Trieste-Monfalcone area, Italy. Occupational data were collected from the patients or from their relatives by personal or telephone interviews. Routine lung sections were examined for asbestos bodies in 370 cases. Latency periods, calculated in 312 cases, ranged from 14 to 72 years (mean 48.7, median 51). Latency periods differed significantly from one occupational group to another. Mean latency periods were 29.6 among insulators, 35.4 among dock workers, 43.7 in a heterogeneous group defined as various, 46.4 in non-shipbuilding industry workers, 49.4 in shipyard workers, 51.7 among women with a history of domestic exposure to asbestos, and 56.2 in people employed in maritime trades. The ANOVA test indicated a correlation between latency periods an.
All cases of pleural malignant mesothelioma occurring in Tuscany were collected, backdated to 1980 (to 1970 for the provinces of Florence and Prato; to 1975 for the provinces of Pisa and Siena), in order to evaluate the incidence of occupational exposure to asbestos. The aim was to enhance primary prevention in those workplaces still at risk nowadays. To achieve information on the possible occupational, domestic or environmental exposure, an interview was conducted using a semi-structured questionnaire. An exposure classification was produced to focus preventive intervention. This surveillance system needs to be developed to contribute to epidemiological research, especially on the effects of low level exposures, and to primary prevention. _________________________________________________________ Med Lav 1997 Jul-Aug;88(4):302-9
Mesothelioma Attorney Houston | Mesothelioma Lawyer | Mesothelioma Attorney | Mesotheleoma Attorney Texas | Mesotheleoma | Mesothelioma Settlement | Mesothelioma Treatment | Mesotheliom | Mesothelioma Cancer | Malignant Mesothelioma | Mesothelioma Information | Mesotheleoma Litigation | Mesothlioma Asbestos | Peritoneal Mesothelioma | . |. |. |
(c) Copyright 2009